Page 1 of Clinical Trials for Drug SPM 907, 5 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome
Last Updated: November 21, 2008
Condition(s): Overactive Bladder Syndrome
2
Completed
Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome
Last Updated: November 21, 2008
Condition(s): Overactive Bladder Syndrome
3
Completed
Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension Phase
Last Updated: October 15, 2008
Condition(s): Overactive Bladder
4
Completed
A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome
Last Updated: April 29, 2008
Condition(s): Overactive Bladder Syndrome
5
Completed
Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome
Last Updated: April 9, 2008
Condition(s): Overactive Bladder

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+SPM+907

Page 1 of Clinical Trials for Drug SPM 907, 5 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About